银杏达莫联合舒血宁治疗出血性脑梗死的疗效

Curative effect of ginkgo dipyidamolum and Shuxuening on hemorrhagic cerebral infarction

目的观察银杏达莫联合舒血宁治疗出血性脑梗死患者的治疗效果，提高出血性脑梗死患者的治愈率。方法选择2013年1月～2015年2月在我院进行治疗的100例出血性脑梗死患者为研究对象，将所有患者按照随机数字法分为研究组和对照组各50例。研究组患者采用银杏达莫联合舒血宁治疗，对照组只采用舒血宁治疗，比较两组患者治疗前后的各项临床指标。结果经过一段时间的治疗后，两组患者的红细胞压积、全血低切粘度、全血高切粘度均有显著差异（均P〈0．05）。研究组患者的治愈率为48％，对照组患者的治愈率为18％，两组间治愈率差异亦有统计学意义（P〈0．05）。结论银杏达莫联合舒血宁治疗出血性脑梗死更加有效，能改善血液指标，显著提高患者的治愈率和神经功能，值得临床推广应用。

Objective To explore the curative effect of ginkgo dipyidamolum and Shuxuening on hemorrhagic cerebral infarction. Methods 100 hemorrhagic cerebral infarction patients were divided into research group and control group. The research group was treated with ginkgo dipyidamolum and Shuxuening. The control group was treated with Shuxuening. The clinical indicators were observed. Results The hematocrit, low cut blood viscosity and high cut blood viscosity of research group and control group were improved after treatment. The curative rate of research group （48%） was higher than that of control group （18%） （P〈0.05）. Conclusion Ginkgo dipyidamolum and Shuxuening is effective in patients with hemorrhagic cerebral infarction, which can improve blood indexes, the cure rate of patients and the patientrs neurologic.